ClinicalTrials.Veeva

Menu

Peripheral Nerve Stimulation(PNS) for Subacromial Impingement Syndrome(SIS)

MetroHealth Medical Center logo

MetroHealth Medical Center

Status

Completed

Conditions

Shoulder Bursitis
Shoulder Pain
Shoulder Tendinitis
Pain, Shoulder
Shoulder Impingement Syndrome

Treatments

Other: Physical Therapy
Device: Non Contracting Producing Peripheral Nerve Stimulation
Device: Contracting Producing Peripheral Nerve Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT03752619
IRB17-00643

Details and patient eligibility

About

Shoulder pain accounts for 16% of all musculoskeletal complaints in the healthy adult population. Subacromial impingement syndrome (SIS) is the most common cause of shoulder pain. Many patients with chronic pain from subacromial impingement syndrome (SIS) will fail treatment efforts and have longstanding pain. This project will evaluate the efficacy of a novel approach to treatment, percutaneous peripheral nerve stimulation, for participants with chronic shoulder pain due to subacromial impingement syndrome (SIS).

Full description

The medical and socioeconomic impact of subacute and chronic shoulder pain is high, resulting in 12 million visits to physicians and over $7 billion in direct costs in the United States. The most common cause is subacromial impingement syndrome (SIS), which accounts for 30% of all shoulder pain. Approximately 35% of patients who present with subacromial impingement syndrome (SIS) are refractory to conservative management. For patients who have failed conservative management, there are no established treatments to reduce the pain. The long-term goal is to develop a therapeutic intervention to reduce pain related to subacromial impingement syndrome(SIS). A pilot trial of 3-week percutaneous peripheral nerve stimulation (PNS) for participants with chronic shoulder pain due to subacromial impingement syndrome (SIS) that was refractory to conservative treatment that showed 60% of participants had successful treatment of pain that lasted at least 3 months. Thus, the primary objective of this 2 site randomized control trial (RCT) is to confirm the findings of this preliminary trial and determine the efficacy of peripheral nerve stimulation (PNS) for chronic subacromial impingement syndrome (SIS). The secondary objectives of this multisite randomized control trial (RCT) is to explore mechanisms of peripheral nerve stimulation (PNS) for the treatment of subacromial impingement syndrome (SIS), and to determine which characteristics can predict successful treatment with peripheral nerve stimulation (PNS). In order to accomplish these objectives, this trial is a multi-site, placebo controlled, double-blinded randomized control trial (RCT) to compare the efficacy of peripheral nerve stimulation (PNS) to sham peripheral nerve stimulation (PNS). Measures of pain, pain interference with activities of daily living (ADLs), capacity for activities of daily living (ADLs), Quality of life (QoL), and measures of central sensitization (pain thresholds, secondary hyperalgesia, and temporal summation) will be measured. Participants will be followed for a total of 24 weeks after treatment has concluded.

Enrollment

116 patients

Sex

All

Ages

21 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Shoulder pain of >3 months
  2. Age>=21
  3. Worst pain in the last week>=4 (0-10 scale)
  4. Ability to check skin and perform dressing changes, independently or with assistance
  5. Stable dose of pain medication (Not taking more than than 1 opioid or 1 non-opioid analgesic)

Exclusion criteria

  1. Current shoulder joint or overlying skin infection, or current bacterial infection requiring antibiotics
  2. Other chronic pain syndrome (Pain in another area of the body 15 or more days in the last 30 (more than half of the time) or taking daily analgesics for another pain syndrome)
  3. Prior shoulder surgery to ipsilateral shoulder joint (glenohumeral, rotator cuff, acromioclavicular (AC) Joint, etc.)
  4. Corticosteroid injection in the ipsilateral shoulder or any other pain relieving treatment in last 12 weeks
  5. Uncontrolled bleeding disorder
  6. Medical instability based on physician opinion after review of medical information
  7. Pregnancy
  8. Neurological condition affecting ipsilateral upper limb (such as central neurologic injury/illness, radiculopathy, diabetic amyotrophy, Complex Regional Pain Syndrome, etc.)
  9. Current Worker's compensation claim for the ipsilateral shoulder
  10. Shoulder instability, severe glenohumeral osteoarthritis(OA) based on patient symptoms and physical examination
  11. Ipsilateral shoulder injury due to severe trauma (Fall from greater than standing height; Motor vehicle crashes; Struck by vehicle or other fast-moving projectile (e.g., bullet, baseball, etc.); Assault (i.e., injuries intentionally inflicted by another person))
  12. Current osseus fracture in ipsilateral arm
  13. Ipsilateral upper limb amputation other than a single digit (digits 2-5, partial or full)
  14. Surgical indication for shoulder treatment based on physician opinion
  15. Compromised immune system (immunodeficiency or immunosuppression)
  16. Current use of a Deep Brain Stimulation (DBS) system, implanted active cardiac implant (e.g. pacemaker or defibrillator), any other implantable neuro-stimulator whose stimulus current pathway may overlap with that of the SPRINT System
  17. Patients who have a tape or adhesive allergy
  18. Contraindication to Magnetic resonance imaging (metal in body, claustrophobia, body habitus, etc) - exclude from Magnetic resonance imaging (MRI) only

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

116 participants in 2 patient groups

Contraction Producing Peripheral Nerve Stimulation
Experimental group
Description:
This group will receive: 1) muscle contraction producing peripheral nerve stimulation treatment (which will produce muscle contraction) for three weeks (6 hours daily); and, 2) physical therapy.
Treatment:
Device: Contracting Producing Peripheral Nerve Stimulation
Other: Physical Therapy
Non Contracting Producing Peripheral Nerve Stimulation
Active Comparator group
Description:
This group will receive: 1) non contraction producing peripheral nerve stimulation treatment (which will not produce muscle contraction) for three weeks (6 hours daily); and, 2) physical therapy.
Treatment:
Device: Non Contracting Producing Peripheral Nerve Stimulation
Other: Physical Therapy

Trial documents
1

Trial contacts and locations

2

Loading...

Central trial contact

Kristine Hansen, PT

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems